The only party not getting heartburn over GSK demerger is the lawyers | Nils Pratley
The Guardian - Pharmaceutical Industry
SEPTEMBER 20, 2022
The depressing outcome of the split is a legal challenge in the US over Zantac that will run on for years Lawyers at pharmaceutical companies are more important than the scientists, runs an old and cynical piece of industry wisdom.
Let's personalize your content